A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam

Background: COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There is currently no vaccine to prevent COVID-19 or therapeutic agent to treat COVID-19. This clinical trial is designed to evaluate chloroquine as a potential th...

詳細記述

保存先:
書誌詳細
出版年:Wellcome Open Res
主要な著者: Kestelyn, Evelyne, Dung, Nguyen Thi Phuong, Lam Minh, Yen, Hung, Le Manh, Quan, Nguyen Minh, Dung, Nguyen Thanh, Minh, Ngo Ngoc Quang, Xuan, Tran Chanh, Phong, Nguyen Thanh, Ninh Thi Thanh, Van, Donovan, Joseph, Tu, Tran Nguyen Hoang, Nhat, Le Thanh Hoang, Truong, Nguyen Thanh, Man, Dinh Nguyen Huy, Thao, Huynh Phuong, Ngoc, Nghiêm My, Lam, Vo Thanh, Phat, Huynh Hong, Phuong, Phan Minh, Geskus, Ronald B., Ha, Vo Thi Nhi, Quang, Nguyen Ngo, Tran Tinh, Hien, Tan, Le Van, Thwaites, Guy E., Day, Jeremy N., Chau, Nguyen Van Vinh
フォーマット: Artigo
言語:Inglês
出版事項: F1000 Research Limited 2020
主題:
Study Protocol
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7573712/
https://ncbi.nlm.nih.gov/pubmed/33110944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.15936.1
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料